
Research area
Weight & Metabolism
Metabolic, weight and receptor research: incretin drugs, growth-hormone fragments and enzyme inhibitors.
Weight & Metabolism references
Research updates
Recent developments
The latest dated changes for weight & metabolism references. See all research updates.
Psoriatic arthritis data at ACR
Lilly presents TOGETHER-PsA, a phase 3b study of ixekizumab with tirzepatide in psoriatic arthritis with obesity.
Read the sourceTRIUMPH-4 at ACR Convergence
Lilly presents the 68-week phase 3 TRIUMPH-4 trial in knee osteoarthritis pain as a plenary; knee data from TRIUMPH-1 follow on November 10.
Read the sourceFirst head-to-head phase 3
Sponsor-reported TRANSCEND-T2D-2 results compare retatrutide with semaglutide 2 mg in type 2 diabetes over 80 weeks. Full results are not yet published.
Read the sourceTRIUMPH-1 and TRIUMPH-2 published
TRIUMPH-1 appeared in NEJM and TRIUMPH-2 in The Lancet.
Read the source



